We don't know much about this study yet.We're trying to become the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.
Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.
Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.
Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.
Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.
Minoxidil causes excessive hair growth in almost all patients.